News

Filter

Current filters:

HerceptinGenentech

1 to 9 of 183 results

San Antonio breast cancer meeting highlights

10-12-2012

There was mixed news coming out of the San Antonio Breast Cancer Symposium (SABCS), which concluded on…

AvastinBiotechnologyEisaiGenentechHerceptinOncologyPerjetaPharmaceuticalResearchRoche

US FDA approves Genentech/Roche’s Herceptin for HER2-positive metastatic stomach cancer; Roche amends deal with Biogen

22-10-2010

US biotech giant Genentech, part of Swiss drug major Roche (ROG: VX), says the US Food and Drug Administration…

Biogen IdecGenentechHerceptinLicensingNorth AmericaocrelizumabOncologyPharmaceuticalRegulationRoche

PDL BioPharma sues Roche’s Genentech over royalties

02-09-2010

US drug developer PDL BioPharma (Nasdaq: PDL) said yesterday that it has filed suit in a Nevada state…

AvastinBiotechnologyFinancialGenentechHerceptinLegalLucentisPDL BioPharmaPharmaceuticalRocheXolair

Seattle Genetics hires new commercial chief, promotes legal exec

14-10-2009

US biotechnology firm Seattle Genetics has appointed Bruce Seeley executive vice president, commercial.…

Aventis PharmaBiotechnologyGenentechHerceptinNorth AmericaRochetrastuzumab

1 to 9 of 183 results

COMPANY SPOTLIGHT

Menarini

Back to top